In addition, MAPK signaling pathway is interconnected with PI3K-AKT signaling pathway [97], and approximately 30–40% CRC patients harbor a mutation in KRAS [70], which is a part of RAS-RAF-MAPK cascade joining in the cellular function of CRC cells [98]. This evidence concerns the gene PIK3CA and colorectal carcinoma.